作者
Jorge J Castillo, Thomas Guerrero‐Garcia, Francesco Baldini, Emmanuelle Tchernonog, Guillaume Cartron, Slavisa Ninkovic, Kate Cwynarski, Daan Dierickx, Thomas Tousseyn, Frederick Lansigan, Yevgeny Linnik, Renzo Mogollon, Jose‐Tomás Navarro, Adam J Olszewski, John L Reagan, Pasquale Fedele, Michael Gilbertson, George Grigoriadis, Michele Bibas
发表日期
2019/2/15
来源
British journal of haematology
卷号
184
期号
4
简介
The article offers information on a study related to the effectiveness of bortezomib in combination with EPOCH (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin) medication in the treatment of patients with plasmablastic lymphoma. It notes the overall survival estimates for the group as per HIV status (human immunodeficiency virus), IPI (International Prognostic Index) and PBL (plasmablastic lymphoma).
学术搜索中的文章
JJ Castillo, T Guerrero‐Garcia, F Baldini, E Tchernonog… - British journal of haematology, 2019